Dole (NYSE:DOLE) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Dole (NYSE:DOLE – Free Report) from a hold rating to a buy rating in a research report released on Saturday. A number of other equities analysts also recently commented on DOLE. Stephens started coverage on shares of Dole in a research note on Friday, September 12th. They issued an […]
AngloGold Ashanti (NYSE:AU) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of AngloGold Ashanti (NYSE:AU – Free Report) from a hold rating to a buy rating in a report issued on Saturday. A number of other analysts also recently issued reports on the stock. HSBC reaffirmed a “reduce” rating and set a $55.00 price objective on shares of AngloGold Ashanti in […]
Affirm (NASDAQ:AFRM) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Affirm (NASDAQ:AFRM – Free Report) from a hold rating to a buy rating in a report released on Saturday morning. AFRM has been the subject of several other research reports. Bank of America boosted their target price on shares of Affirm from $94.00 to $98.00 and gave the company […]
Twin Disc (NASDAQ:TWIN) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Twin Disc (NASDAQ:TWIN – Free Report) from a hold rating to a buy rating in a report issued on Saturday. Several other brokerages have also issued reports on TWIN. Zacks Research upgraded shares of Twin Disc to a “hold” rating in a research report on Tuesday, December 9th. Weiss […]
Wall Street Zen Downgrades Yext (NYSE:YEXT) to Buy
Yext (NYSE:YEXT – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Sunday. Several other equities analysts have also commented on the stock. Zacks Research lowered shares of Yext from a “strong-buy” rating to a […]
CMS Energy (NYSE:CMS) Cut to Sell at Wall Street Zen
Wall Street Zen cut shares of CMS Energy (NYSE:CMS – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday. A number of other research firms have also recently issued reports on CMS. Wells Fargo & Company upgraded CMS Energy to a “hold” rating in a […]
Wall Street Zen Downgrades Buckle (NYSE:BKE) to Hold
Buckle (NYSE:BKE – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Sunday. Several other equities analysts have also issued reports on the stock. UBS Group restated a “neutral” rating on shares of Buckle in a […]
WAVE Life Sciences (NASDAQ:WVE) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of WAVE Life Sciences (NASDAQ:WVE – Free Report) from a sell rating to a hold rating in a report published on Saturday. Other analysts also recently issued reports about the company. Citigroup upped their price objective on WAVE Life Sciences from $16.00 to $30.00 and gave the company a “buy” […]
Curtiss-Wright (NYSE:CW) Cut to Hold at Wall Street Zen
Wall Street Zen lowered shares of Curtiss-Wright (NYSE:CW – Free Report) from a buy rating to a hold rating in a report issued on Saturday morning. A number of other equities analysts also recently commented on the stock. Citigroup began coverage on shares of Curtiss-Wright in a research note on Thursday. They issued a “neutral” […]
Sionna Therapeutics (NASDAQ:SION) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Sionna Therapeutics (NASDAQ:SION – Free Report) from a sell rating to a hold rating in a research report report published on Saturday. A number of other equities research analysts have also recently commented on the stock. Raymond James Financial restated a “strong-buy” rating on shares of Sionna Therapeutics in […]
Sionna Therapeutics (NASDAQ:SION) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Sionna Therapeutics (NASDAQ:SION – Free Report) from a sell rating to a hold rating in a research report report published on Saturday. A number of other equities research analysts have also recently commented on the stock. Raymond James Financial restated a “strong-buy” rating on shares of Sionna Therapeutics in […]
Taysha Gene Therapies (NASDAQ:TSHA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday. Several other analysts also recently weighed in on the stock. Citigroup reiterated an “outperform” rating on shares of Taysha Gene Therapies in a research report […]
Affiliated Managers Group (NYSE:AMG) Cut to “Hold” at Wall Street Zen
Wall Street Zen downgraded shares of Affiliated Managers Group (NYSE:AMG – Free Report) from a buy rating to a hold rating in a report released on Saturday morning. A number of other research analysts have also weighed in on AMG. Barrington Research raised their price objective on shares of Affiliated Managers Group from $285.00 to […]
Vinci Compass Investments (NASDAQ:VINP) Rating Lowered to “Hold” at Wall Street Zen
Vinci Compass Investments (NASDAQ:VINP – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Sunday. A number of other analysts have also recently weighed in on the stock. UBS Group boosted their price objective on shares of […]
DICK’S Sporting Goods (NYSE:DKS) Cut to Sell at Wall Street Zen
Wall Street Zen cut shares of DICK’S Sporting Goods (NYSE:DKS – Free Report) from a hold rating to a sell rating in a research report report published on Saturday morning. Several other research analysts have also issued reports on the stock. Wells Fargo & Company upped their target price on shares of DICK’S Sporting Goods […]
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Rating Upgraded by Wall Street Zen
Arcutis Biotherapeutics (NASDAQ:ARQT – Get Free Report) was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Sunday. ARQT has been the topic of several other research reports. The Goldman Sachs Group increased their price target on Arcutis Biotherapeutics from $19.00 to $29.00 and […]
last updated on 16 Dec 07:59